ZUBRIN 200 ANTI-INFLAMMATORY TABLETS FOR DOGS

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

Buy It Now

Active ingredient:
TEPOXALIN
Available from:
Intervet Australia Pty Limited
INN (International Name):
tepoxalin(200mg/Tb)
Pharmaceutical form:
ORAL TABLET
Composition:
TEPOXALIN UNGROUPED Active 200.0 mg/Tb
Units in package:
10 Tablets; 30 Tablets; 60 Tablets
Class:
VM - Veterinary Medicine
Manufactured by:
INTERVET AUSTRALIA
Therapeutic group:
DOG | BITCH | CASTRATE | PUPPY
Therapeutic area:
MUSCULOSKELETAL SYSTEM
Therapeutic indications:
ANTI-INFLAMMATORY AGENT | MUSCULOSKELETAL CONDITIONS | ANTIPYRETIC | ARTHRITIS | ARTHROSIS | BONE SORENESS | BRUISING | BURSITIS | EXTERNAL MYOPATHY | INFLAMATION OF SOFT TISSUES AN | INFLAMMATORY RHEUMATIC ARTHRIT | JOINT DISEASE | LIGAMENT SPRAINS | MUSCLE SORENESS | OSTEITIS | OSTEOARTHRITIS | PLATELET ACTIVITY | RHEUMATISM | SPRAINS | STRAINS | TENDON AND LIGAMENT SPRAINS | TENDON SPRAINS | TENDONITIS | TENOSYNOVITIS | TRAUMATIC JOINT AND CONNECTIVE | TRAUMATIC SWELLING
Product summary:
Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: DOG: [ANTI-INFLAMMATORY AGENT, MUSCULOSKELETAL CONDITIONS]; Poison schedule: 4; Withholding period: ; Host/pest details: DOG: [ANTI-INFLAMMATORY AGENT, MUSCULOSKELETAL CONDITIONS]; A non steroidal anti inflammatory for the reduction of inflammation and relief of pain associated with musculoskeletal disorders in dogs.
Authorization status:
Registered
Authorization number:
52539
Authorization date:
2020-07-01

________________________________________________________________________

Schering-Plough Corporation

Global Supply Chain

1095 Morris Avenue

Union, New Jersey 07083-7143

Telephone (908) 298-4000

Zubrin

Rapidly-Disintegrating Tablets

(EX000034)

This product is exempt from [Material] Safety Data Sheet requirements.

The following regional exemptions apply:

United States:

According to the OSHA Hazard Communication Standard [29 CFR § 1910.1200 (b) (6) (vii)], an MSDS is

not required for any drug when it is in the solid, final form (e.g. tablets or pills).

European Union:

According to the European Union Commission Directive 2001/58/EC of 27 July 2001, as it relates to

Directive 1999/45/EC [Article 1.5.a], an SDS is not required for medicinal products in the finished state,

intended for the final user.

Canada:

According to the WHMIS Hazardous Product Act [Part II Controlled Products 12.b], an MSDS is not

required for any drug within the meaning of the Food and Drugs Act.

If you have any questions or need assistance, please call Schering-Plough Animal Health

Corporation at 800- 932-0473. Many Schering-Plough Animal Health [Material] Safety Data

Sheets may be obtained through the MSDS HelpLine at 800-770-8878 or from the S-P MSDS

website at www.schering-ploughmsds.com.

Technical inquiries for adverse events in animals for Schering-Plough Animal Health Products may

be addressed to Schering-Plough Animal Health Technical Services:

For Small Animals and Horses (800) 224-5318

For Livestock (800) 211-3573

For Poultry (800) 219-9286

Sincerely,

Global Safety & Environmental Affairs

Schering-Plough Corporation

Schering-Plough

Global Safety & Environmental Affairs

Similar products

Search alerts related to this product

View documents history

Share this information